Additional Hyperbaric Oxygen After Lower Extremity Amputation (AHOLEA)
Additional Hyperbaric Oxygen After Lower Extremity Amputation - a Randomized Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Jonas Rydinge, MD
- Phone Number: +47 92291795 +4792291795
- Email: jonryd@ous-hf.no
Study Contact Backup
- Name: Elisabeth I Ellingsen Husebye, MD, PhD
- Phone Number: +47 95133773 +47 95133773
- Email: uxngng@ous-hf.no
Study Locations
-
-
-
Oslo, Norway, 0319
- Recruiting
- Diakonhjemmet Hospital
-
Contact:
- Mads Sundet, MD
- Phone Number: +4741661770
- Email: mads.sundet@icloud.com
-
Contact:
- Mads Sundet, MD
-
Oslo, Norway, 0407
- Recruiting
- Orthopedic Center, Ullevål University Hopspital
-
Contact:
- Elisabeth Ellingsen Husebye, MD, PhD
- Phone Number: +47 23027884
-
Contact:
- Jonas Rydinge
- Phone Number: +47 92291795 +47 92291795
- Email: jonryd@ous-hf.no
-
Contact:
- Jonas Rydinge, MD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Lower extremity amputation because of chronic wound, osteomyelitis, ischemia, necrosis.
- Fit to receive hyperbaric oxygen therapy determined by an anesthesiologist/Hyperbaric Medicine Physician.
- Able to cooperate and follow up appointments
- Included within 7 days after final surgery
Exclusion Criteria:
- Not fulfilling inclusion criteria
- Pregnancy
- Dementia
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Hyperbaric oxygen therapy
30 sessions of Hyperbaric oxygen therapy, 90min treatment at 2,4 ATA(atmosphere absolute) with 100% oxygen.First session must be given within 7 days after initial amputation.
Treatment is given as outpatient treatment after discharge from hospital.
|
Breathing 100% oxygen for 30+30+30 min at 2,4 ATA. in a multiplace hyperbaric chamber.
Total of 30 sessions
|
|
No Intervention: Control group
Control group will be given standard of care with follow up at the outpatient clinic after discharge from hospital.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intact skin with no abnormal openings at the site of primary amputation
Time Frame: 12 weeks
|
Healed and intact skin at the site of primary amputation without need for more proximal amputation.Healed amputation is defined as epithelialization of the wound examined by a orthopedic surgeon.
Level of primary amputation is decided by the surgeon.
Planned 2-session amputation, for example Guillotine amputation with a final amputation later is considered being primary amputation.
Healed primary amputation will be measured at 12 weeks.
|
12 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intact skin with no abnormal openings at the site of amputation at 6 months
Time Frame: 6 months
|
Healed and intact skin at the site of amputation at follow up 6 months.
Healed amputation is defined as epithelialization of the wound examined by a orthopedic surgeon.
|
6 months
|
|
Intact skin with no abnormal openings at the site of amputation at 9 months
Time Frame: 9 months
|
Healed and intact skin at the site of amputation at follow up 9 months.
Will be assessed if the wound has not healed at 6 months.
Healed amputation is defined as epithelialization of the wound examined by a orthopedic surgeon.
|
9 months
|
|
Intact skin with no abnormal openings at the site of amputation at 1 year
Time Frame: 12 months
|
Healed and intact skin at the site of amputation at follow up at 1 year.
Healed amputation is defined as epithelialization of the wound examined by a orthopedic surgeon.
|
12 months
|
|
Time to closed and intact skin at the site of amputation
Time Frame: 1 year
|
Time to closed and intact skin at the site of amputation is the defined as how many weeks until complete healing of amputation.
Healed amputation is defined as epithelialization of the wound examined by a orthopedic surgeon and no abnormal openings.
|
1 year
|
|
Reamputations
Time Frame: 1 year
|
The total number of reamputations done within the follow-up period of 1 year.
|
1 year
|
|
Number of wound revision
Time Frame: 1 year
|
The total numbers of surgical wound revision done in operating theater.
|
1 year
|
|
Days in hospital during follow up
Time Frame: 1 year
|
Total number of days in hospital during 1 year follow up
|
1 year
|
|
Visual analog pain scale (VAS)
Time Frame: baseline
|
Visual analog pain scale (VAS) is a measurement of pain intensity between 0 and 10. 0 = no pain, 10 = worst imaginable pain.
|
baseline
|
|
Visual analog pain scale (VAS)
Time Frame: 12 weeks
|
Visual analog pain scale (VAS) is a measurement of pain intensity between 0 and 10. 0 = no pain, 10 = worst imaginable pain.
|
12 weeks
|
|
Visual analog pain scale (VAS)
Time Frame: 6 months
|
Visual analog pain scale (VAS) is a measurement of pain intensity between 0 and 10. 0 = no pain, 10 = worst imaginable pain.
|
6 months
|
|
Visual analog pain scale (VAS)
Time Frame: 1 year
|
Visual analog pain scale (VAS) is a measurement of pain intensity between 0 and 10. 0 = no pain, 10 = worst imaginable pain.
|
1 year
|
|
RAND 36-Item Short Form Health Survey
Time Frame: baseline
|
RAND 36-Item Short Form Health Survey (SF-36) measures 8 health domains with the total of 36 questions.
The domains are physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions.
There is also 1 question that measures change in self-perceived health.The question answers is translated to a number between 0 meaning worst selv-perceived health and 100 meaning the best possible quality of health.Each domain will be presented with a number between 0 and 100.
|
baseline
|
|
RAND 36-Item Short Form Health Survey
Time Frame: 12 weeks
|
RAND 36-Item Short Form Health Survey (SF-36) measures 8 health domains with the total of 36 questions.
The domains are physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions.
There is also 1 question that measures change in self-perceived health.The question answers is translated to a number between 0 meaning worst selv-perceived health and 100 meaning the best possible quality of health.Each domain will be presented with a number between 0 and 100.
|
12 weeks
|
|
RAND 36-Item Short Form Health Survey
Time Frame: 6 months
|
RAND 36-Item Short Form Health Survey (SF-36) measures 8 health domains with the total of 36 questions.
The domains are physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions.
There is also 1 question that measures change in self-perceived health.The question answers is translated to a number between 0 meaning worst selv-perceived health and 100 meaning the best possible quality of health.Each domain will be presented with a number between 0 and 100.
|
6 months
|
|
RAND 36-Item Short Form Health Survey
Time Frame: 1 year
|
RAND 36-Item Short Form Health Survey (SF-36) measures 8 health domains with the total of 36 questions.
The domains are physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions.
There is also 1 question that measures change in self-perceived health.The question answers is translated to a number between 0 meaning worst selv-perceived health and 100 meaning the best possible quality of health.Each domain will be presented with a number between 0 and 100.
|
1 year
|
|
Quality of Life in Neurological Disorders - Lower extremity function - Mobility Short form
Time Frame: baseline
|
Quality of Life in Neurological Disorders (Neuro-QoL) - Lower extremity function - Mobility Short form measures lower extremity function with 8 items scoring from 1 unable to do, to 5 which is doing it without any difficulty.
Scores will be presented as total points from 5-40.
|
baseline
|
|
Quality of Life in Neurological Disorders - Lower extremity function - Mobility Short form
Time Frame: 12 weeks
|
Quality of Life in Neurological Disorders (Neuro-QoL) - Lower extremity function - Mobility Short form measures lower extremity function with 8 items scoring from 1 unable to do, to 5 which is doing it without any difficulty.
Scores will be presented as total points from 5-40.
|
12 weeks
|
|
Quality of Life in Neurological Disorders - Lower extremity function - Mobility Short form
Time Frame: 6 months
|
Quality of Life in Neurological Disorders (Neuro-QoL) - Lower extremity function - Mobility Short form measures lower extremity function with 8 items scoring from 1 unable to do, to 5 which is doing it without any difficulty.
Scores will be presented as total points from 5-40.
|
6 months
|
|
Quality of Life in Neurological Disorders - Lower extremity function - Mobility Short form
Time Frame: 1 year
|
Quality of Life in Neurological Disorders (Neuro-QoL) - Lower extremity function - Mobility Short form measures lower extremity function with 8 items scoring from 1 unable to do, to 5 which is doing it without any difficulty.
Scores will be presented as total points from 5-40.
|
1 year
|
|
The Foot and Ankle Ability Measure (FAAM)
Time Frame: baseline
|
The Foot and Ankle Ability Measure (FAAM) is a self-report outcome instrument developed to assess physical function for individuals with foot and ankle related impairments.
FAAM contains 21 items that measure different functions.
Each answer get a score from 0 to 4. The score total will be reported were 0 is the lowest and 84 is the highest possible score.
|
baseline
|
|
The Foot and Ankle Ability Measure (FAAM)
Time Frame: 12 weeks
|
The Foot and Ankle Ability Measure (FAAM) is a self-report outcome instrument developed to assess physical function for individuals with foot and ankle related impairments.
FAAM contains 21 items that measure different functions.
Each answer get a score from 0 to 4. The score total will be reported were 0 is the lowest and 84 is the highest possible score.
|
12 weeks
|
|
The Foot and Ankle Ability Measure (FAAM)
Time Frame: 6 months
|
The Foot and Ankle Ability Measure (FAAM) is a self-report outcome instrument developed to assess physical function for individuals with foot and ankle related impairments.
FAAM contains 21 items that measure different functions.
Each answer get a score from 0 to 4. The score total will be reported were 0 is the lowest and 84 is the highest possible score.
|
6 months
|
|
The Foot and Ankle Ability Measure (FAAM)
Time Frame: 1 year
|
The Foot and Ankle Ability Measure (FAAM) is a self-report outcome instrument developed to assess physical function for individuals with foot and ankle related impairments.
FAAM contains 21 items that measure different functions.
Each answer get a score from 0 to 4. The score total will be reported were 0 is the lowest and 84 is the highest possible score.
|
1 year
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Jonas V Rydinge, MD, Ullevål University Hospital, orthopedic department
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Endocrine System Diseases
- Bone Diseases
- Musculoskeletal Diseases
- Nervous System Diseases
- Vascular Diseases
- Cardiovascular Diseases
- Pathologic Processes
- Neuromuscular Diseases
- Chronic Disease
- Disease Attributes
- Infections
- Peripheral Nervous System Diseases
- Diabetes Mellitus
- Diabetes Complications
- Bone Diseases, Infectious
- Skin Diseases
- Skin Ulcer
- Atherosclerosis
- Arteriosclerosis
- Arterial Occlusive Diseases
- Peripheral Vascular Diseases
- Ischemia
- Foot Ulcer
- Peripheral Arterial Disease
- Chronic Limb-Threatening Ischemia
- Leg Ulcer
- Diabetic Neuropathies
- Diabetic Foot
- Intermittent Claudication
- Osteomyelitis
- Diabetic Angiopathies
Other Study ID Numbers
Other Study ID Numbers
- 2017/1587
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.